Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibody-Drug Conjugates (ADCs)
    (29)
  • ADC Antibody
    (1)
  • EGFR
    (1)
  • Immunology/Inflammation related
    (1)
  • Microtubule Associated
    (1)
  • TROP2
    (1)
  • Topoisomerase
    (1)
  • c-Met/HGFR
    (1)
Filter
Search Result
Results for "

antibodydrugconjugates(adcs)

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    27
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    2
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    30
    TargetMol | Inhibitory_Antibodies
Trastuzumab deruxtecan
VRN-101099, T-DXd, DS-8201a, DS 8201
T366461826843-81-5
Trastuzumab deruxtecan (T-DXd) is an antibody-active molecule conjugate (ADC) with anticancer and antitumor activity, which is composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) coupled to a topoisomerase I inhibitor (DXd). Trastuzumab deruxtecan has an improved effect on the treatment of HER2-positive breast cancer and gastric cancer.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Enfortumab vedotin-ejfv
T780651346452-25-2
Enfortumab vedotin-ejfv (Padcev) is an ADC compound targeting Nectin-4 with anti-tumor activity, used in the study of urothelial carcinoma.
  • Inquiry Price
2-4 weeks
Size
QTY